Editorial: The molecular landscape and promising therapeutic targets in aggressive B-cell non-Hodgkin lymphomas

被引:0
|
作者
Witte, Hanno Maximilian [1 ,2 ,3 ]
Kuenstner, Axel [3 ,4 ]
Chteinberg, Emil [5 ,6 ]
Piazza, Francesco [7 ,8 ]
Roue, Gael [9 ]
Gebauer, Niklas [2 ,3 ]
机构
[1] Bundeswehrkrankenhaus Ulm, Dept Hematol & Oncol, Ulm, Germany
[2] Univ Hosp Schleswig Holstein, Dept Hematol & Oncol, Lubeck, Germany
[3] Univ Hosp Schleswig Holstein, Univ Canc Ctr Schleswig Holstein, Lubeck, Germany
[4] Univ Lubeck, Med Syst Biol Grp, Lubeck, Germany
[5] Ulm Univ, Inst Human Genet, Ulm, Germany
[6] Ulm Univ, Med Ctr, Ulm, Germany
[7] Univ Padua, Dept Med, Hematol & Clin Immunol Unit, Padua, Italy
[8] Veneto Ist Mol Med, Myeloma & Lymphoma Pathobiol Lab, Padua, Italy
[9] Josep Carreras Leukaemia Res Inst, Lymphoma Translat Grp, Badalona, Spain
来源
FRONTIERS IN ONCOLOGY | 2023年 / 13卷
关键词
aggressive B-cell lymphoma; non-Hodgkin lymphoma; genomics; transcriptomics; multi-omics; precision oncology;
D O I
10.3389/fonc.2023.1278169
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页数:3
相关论文
共 50 条
  • [21] Expression of inhibitor of apoptosis proteins in B-cell non-Hodgkin and Hodgkin lymphomas
    Akyurek, Nalan
    Ren, Yongsheng
    Rassidakis, Georgios Z.
    Schlette, Ellen J.
    Medeiros, L. Jeffrey
    CANCER, 2006, 107 (08) : 1844 - 1851
  • [22] Therapeutic vaccines for non-Hodgkin B-cell lymphoma
    Briones, Javier
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2008, 10 (09): : 543 - 551
  • [23] Therapeutic vaccines for non-Hodgkin B-cell lymphoma
    Javier Briones
    Clinical and Translational Oncology, 2008, 10 : 543 - 551
  • [24] Analysis of Prognostic Factors in Patients with HIV-Associated Aggressive B-Cell Non-Hodgkin Lymphomas
    Mathew, Blessy
    Dalia, Samir
    Hall, Joseph
    Shah, Bijal
    Bello, Celeste
    Sokol, Lubomir
    Sotomayor, Eduardo
    Chavez, Julio
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2015, 15 : S230 - S230
  • [25] Utility of c-MYC Protein Expression in Prognosticating Aggressive B-Cell Non-Hodgkin Lymphomas
    Allen, A. A.
    Amengual, J. E.
    Alobeid, B.
    Murty, V.
    Bhagat, G.
    Hoehn, D.
    LABORATORY INVESTIGATION, 2014, 94 : 334A - 334A
  • [26] CYTOGENETIC STUDIES OF COMPOSITE LYMPHOMAS - MONOCYTOID B-CELL LYMPHOMA AND OTHER B-CELL NON-HODGKIN LYMPHOMAS
    SLOVAK, ML
    WEISS, LM
    NATHWANI, BN
    BERNSTEIN, L
    LEVINE, AM
    HUMAN PATHOLOGY, 1993, 24 (10) : 1086 - 1094
  • [27] Efficacy and safety of pixantrone for the treatment of multiply relapsed or refractory aggressive non-Hodgkin B-cell lymphomas
    Sancho, Juan-Manuel
    Navarro, Belen
    Campos, Joan Alfons Soler
    de Oteyza, Jaime Perez
    Lekue, Cristina de Barrenetxea
    Bregni, Marco
    Cicala, Silvina Grasso
    Spione, Mario
    Mombiedro, Cristina
    Soler, Begona
    Zinzani, Pier Luigi
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2020, 104 (05) : 499 - 508
  • [28] Utility of c-MYC Protein Expression in Prognosticating Aggressive B-Cell Non-Hodgkin Lymphomas
    Allen, A. A.
    Amengual, J. E.
    Alobeid, B.
    Murty, V.
    Bhagat, G.
    Hoehn, D.
    MODERN PATHOLOGY, 2014, 27 : 334A - 334A
  • [29] Recent molecular and therapeutic advances in B-cell non-Hodgkin lymphoma in children
    Giulino-Roth, Lisa
    Goldman, Stanton
    BRITISH JOURNAL OF HAEMATOLOGY, 2016, 173 (04) : 531 - 544
  • [30] Genomic landscape of mature B-cell non-Hodgkin lymphomas - an appraisal from lymphomagenesis to drug resistance
    Panda, Devasis
    Das, Nupur
    Thakral, Deepshi
    Gupta, Ritu
    JOURNAL OF THE EGYPTIAN NATIONAL CANCER INSTITUTE, 2022, 34 (01)